Nvidia, Pfizer lead $80 million funding for Israeli medical AI tech firm CytoReason

JERUSALEM – Israel’s CytoReason, which uses AI to develop disease models, said on Wednesday it had raised $80 million in a private funding round.

Nvidia, Pfizer, Thermo Fisher and venture capital investor OurCrowd participated in the round, CytoReason said.